130 related articles for article (PubMed ID: 36999567)
21. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
[TBL] [Abstract][Full Text] [Related]
22. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
[TBL] [Abstract][Full Text] [Related]
23. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
24. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
[TBL] [Abstract][Full Text] [Related]
25. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
[TBL] [Abstract][Full Text] [Related]
26. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
27. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
28. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
Talaulikar VS; Conway GS; Pimblett A; Davies MC
Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
[TBL] [Abstract][Full Text] [Related]
29. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.
Walker Z; Lanes A; Ginsburg E
Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479
[TBL] [Abstract][Full Text] [Related]
30. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.
Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V
Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262
[TBL] [Abstract][Full Text] [Related]
31. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.
Sermondade N; Grynberg M; Comtet M; Valdelievre C; Sifer C; Sonigo C
Sci Rep; 2020 Oct; 10(1):18555. PubMed ID: 33122722
[TBL] [Abstract][Full Text] [Related]
32. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
[TBL] [Abstract][Full Text] [Related]
33. Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients.
Tsampras N; Roberts SA; Gould D; Fitzgerald CT
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12797. PubMed ID: 29168588
[TBL] [Abstract][Full Text] [Related]
34. Fertility Preservation Decisions Among Newly Diagnosed Oncology Patients: A Single-Center Experience.
Nurudeen SK; Douglas NC; Mahany EL; Sauer MV; Choi JM
Am J Clin Oncol; 2016 Apr; 39(2):154-9. PubMed ID: 24441581
[TBL] [Abstract][Full Text] [Related]
35. Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation.
Schon SB; Shapiro M; Gracia C; Senapati S
J Assist Reprod Genet; 2017 Sep; 34(9):1207-1215. PubMed ID: 28656539
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
37. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.
Bénard J; Duros S; El Hachem H; Sonigo C; Sifer C; Grynberg M
Future Oncol; 2016 Jul; 12(14):1731-41. PubMed ID: 27184037
[TBL] [Abstract][Full Text] [Related]
38. In vitro maturation of human immature oocytes for fertility preservation.
Chian RC; Uzelac PS; Nargund G
Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
[TBL] [Abstract][Full Text] [Related]
39. Fertility preservation in patients with gynaecologic malignancy: Response to ovarian stimulation and long-term outcomes.
Tsonis O; Kopeika J
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():93-100. PubMed ID: 37757729
[TBL] [Abstract][Full Text] [Related]
40. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
